Viewing Study NCT04090567


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-01-01 @ 8:30 PM
Study NCT ID: NCT04090567
Status: RECRUITING
Last Update Posted: 2025-09-18
First Post: 2019-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module